Michael Arend

2.8k citations

30 papers · 2.4k indexed · 1 hit paper · h-index 18

Impact in

Organic Chemistry top 1%
- Asymmetric Synthesis and Catalysis
- Synthesis and Catalytic Reactions
- Synthetic Organic Chemistry Methods
- Chemical Synthesis and Reactions
- Multicomponent Synthesis of Heterocycles
Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism

Papers in ⓘ

Organic Chemistry 19
- Asymmetric Synthesis and Catalysis 12
- Synthesis and Catalytic Reactions 6
- Synthetic Organic Chemistry Methods 5
- Chemical Synthesis and Reactions 4
- Synthesis of heterocyclic compounds 3
Molecular Biology 14
- Chemical Synthesis and Analysis 9

Co-authors: Nikolaus Risch (13 shared papers)Bernhard Westermann (3 shared papers)Alan R. Katritzky (3 shared papers)Lee A. Flippin (6 shared papers)Kai‐Uwe Eckardt (3 shared papers)Stephen J. Klaus (2 shared papers)Wanja M. Bernhardt (2 shared papers)Michael S. Wiesener (2 shared papers)
Journals: Angewandte Chemie International Edition (2 papers)Synlett (2 papers)Synthesis (2 papers)The Journal of Organic Chemistry (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)
Partner nations: Germany United States Finland

In The Last Decade

Michael Arend

29 papers receiving 2.3k citations

Hit Papers

align trajectories log scale

Modern Variants of the Mannich Reaction 1998 · 972 citations

Peers

Countries citing papers authored by Michael Arend

Since Specialization

Citations

This map shows the geographic impact of Michael Arend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Arend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Arend more than expected).

Fields of papers citing papers by Michael Arend

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Arend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Arend. The network helps show where Michael Arend may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Arend, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Arend Line = papers co-authored together Michael Arend links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Modern Variants of the Mannich Reaction Angewandte Chemie International Edition ·Michael Arend, Bernhard Westermann, Nikolaus Risch Hit paper breakdown →	1998	972
2	Preconditional Activation of Hypoxia-Inducible Factors Ameliorates Ischemic Acute Renal Failure Journal of the American Society of Nephrology ·Wanja M. Bernhardt, Valentina CaCombining Circumflex Accentmpean, Sarah Kany, Jan-Steffen JuCombining Diaeresisrgensen, Alexander Weidemann, Christina Warnecke, Michael Arend, Stephen J. Klaus, Volkmar GuCombining Diaeresisnzler, Kerstin Amann, Carsten Willam, Michael S. Wiesener, Kai‐Uwe Eckardt	2006	241
3	Moderne Varianten der Mannich-Reaktion Angewandte Chemie ·Michael Arend, Bernhard Westermann, Nikolaus Risch	1998	197
4	Hypoxia-inducible factor-2α-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization Kidney International ·Alexander Paliege, Christian Rosenberger, Anja Bondke, Lina K. Sciesielski, Ahuva Shina, Samuel N. Heyman, Lee A. Flippin, Michael Arend, Stephen J. Klaus, Sebastian Bachmann	2009	137
5	Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model Proceedings of the National Academy of Sciences ·Wanja M. Bernhardt, Uwe Göttmann, F Doyon, Bjoern Buchholz, Valentina Câmpean, Johannes Schödel, Anke Reisenbuechler, S J Klaus, Michael Arend, Lee A. Flippin, Carsten Willam, Michael S. Wiesener, Benito Yard, C. Warnecke, Kai‐Uwe Eckardt	2009	119
6	Stimulation of HIF-1α, HIF-2α, and VEGF by prolyl 4-hydroxylase inhibition in human lung endothelial and epithelial cells Free Radical Biology and Medicine ·Tiina M. Asikainen, Aftab Ahmad, Barbara Schneider, Wen‐Bin Ho, Michael Arend, Mitchell C. Brenner, Volkmar Günzler, Carl W. White	2005	87
7	Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney Nephrology Dialysis Transplantation ·Christian Rosenberger, Seymour Rosen, Ahuva Shina, Ulrich Frei, Kai‐Uwe Eckardt, Lee A. Flippin, Michael Arend, S J Klaus, Samuel N. Heyman	2008	73
8	Non-hypoxic Stabilization of Hypoxia-Inducible Factor Alpha (HIF-α): Relevance in Neural Progenitor/Stem Cells Neurotoxicity Research ·Javorina Milošević, Irena Adler, Anatol Manaenko, Sigrid C. Schwarz, Gail Walkinshaw, Michael Arend, Lee A. Flippin, Alexander Storch, Johannes Schwarz	2009	64
9	A Convenient and Highly Regioselective One-Pot Synthesis of Quinolines by Addition of a Vilsmeier-Type Reagent to N-Arylimines The Journal of Organic Chemistry ·Alan R. Katritzky, Michael Arend	1998	58
10	Asymmetric Catalytic Aminoalkylations: New Powerful Methods for the Enantioselective Synthesis of Amino Acid Derivatives, Mannich Bases, and Homoallylic Amines Angewandte Chemie International Edition ·Michael Arend	1999	52
11	Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis Blood ·Anu Laitala, Ellinoora Aro, Gail Walkinshaw, Joni M. Mäki, Maarit Rossi, Minna Heikkilä, Eeva‐Riitta Savolainen, Michael Arend, Kari I. Kivirikko, Peppi Koivunen, Johanna Myllyharju	2012	50
12	Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease Journal of Pharmacology and Experimental Therapeutics ·Ughetta del Balzo, Pierre Signore, Gail Walkinshaw, Todd Seeley, Mitchell C. Brenner, Qingjian Wang, Guangjie Guo, Michael Arend, Lee A. Flippin, F. Aisha Chow, David C. Gervasi, Christian H. Kjaergaard, Ingrid Langsetmo, Volkmar Guenzler, David Y. Liu, S J Klaus, Al Lin, Thomas B. Neff	2020	47
13	Aminoalkylation of Electron-Rich Aromatic Compounds Using Performed Iminium Salts Derived from Aldehydes other than Formaldehyde Synthesis ·Hans‐Joachim Grumbach, Michael Arend, Nikolaus Risch	1996	37
14	A Simple and Versatile Route to Novel Conjugated β-Enaminonitriles and Their Application for the Highly Regioselective Synthesis of Nicotinonitriles Using a Vilsmeier-Type Reagent The Journal of Organic Chemistry ·Alan R. Katritzky, Anna Denisenko, Michael Arend	1999	28
15	Asymmetrische katalytische Aminoalkylierungen: neue leistungsstarke Methoden zur enantioselektiven Synthese von Aminosäurederivaten, Mannich-Basen und Homoallylaminen Angewandte Chemie ·Michael Arend	1999	23
16	Diastereomerically Pure Mannich Bases from the Addition of Enamines to Ternary Iminium Salts Angewandte Chemie International Edition in English ·Nikolaus Risch, Michael Arend	1995	23
17	Synthesis of 2,4,5-Triphenyl-Substituted Oxazolidine and 2,5-Diphenyl-Substituted Pyrrolidine Derivatives Synthesis ·Claudia Wittland, Michael Arend, Nikolaus Risch	1996	21
18	Regio‐ und diastereoselektive Synthese von β‐Aminoketonen durch Addition von Iminen an Iminiumsalze Angewandte Chemie ·Michael Arend, Nikolaus Risch	1995	19
19	Regio‐ and Diastereoselective Synthesis of β‐Amino Ketones by Addition of Imines to Iminium Salts Angewandte Chemie International Edition in English ·Michael Arend, Nikolaus Risch	1996	17
20	Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain Brain Research ·Christina Schneider, Gudrun Krischke, Stephan Sylvest Keller, Gail Walkinshaw, Michael Arend, Wolfgang Rascher, Max Gassmann, Regina Trollmann	2009	16

About Michael Arend

Michael Arend is a scholar working on Organic Chemistry, Molecular Biology, Cancer Research, Genetics and Pharmaceutical Science, having authored 30 papers that have together received 2.4k indexed citations. Recurring topics across this work include Asymmetric Synthesis and Catalysis (12 papers), Cancer, Hypoxia, and Metabolism (10 papers), Chemical Synthesis and Analysis (9 papers), Synthesis and Catalytic Reactions (6 papers), Synthetic Organic Chemistry Methods (5 papers), High Altitude and Hypoxia (5 papers), Chemical Synthesis and Reactions (4 papers) and Synthesis of heterocyclic compounds (3 papers). The work is most often cited by research in Organic Chemistry (1.4k citations), Cancer Research (507 citations), Inorganic Chemistry (284 citations), Nephrology (127 citations) and Hematology (179 citations). Michael Arend has collaborated with scholars based in Germany, United States and Finland. Frequent co-authors include Nikolaus Risch, Bernhard Westermann, Alan R. Katritzky, Lee A. Flippin, Kai‐Uwe Eckardt, Stephen J. Klaus, Wanja M. Bernhardt, Michael S. Wiesener, Carsten Willam and Christian Rosenberger. Their work appears in journals such as Angewandte Chemie International Edition, Synlett, Synthesis, The Journal of Organic Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact